Sponsored By Cutera;

Body contouring continues to account for a major segment of the aesthetic industry and shows no signs of slowing. Thanks to truBody^® by Cutera (Brisbane, Calif.), physicians can add value to their practice with a personalized body suite to help patients reduce fat and tone muscle. The truBody solution combines two award-winning technologies, truSculpt^® and truFlex^™, to deliver a customized, convenient and complete solution that addresses today’s in-demand treatments and delivers results with high patient satisfaction.

“We were getting many requests for nonsurgical body contouring,” reported Michael Somenek, MD, facial plastic and reconstructive surgeon at Somenek+PittmanMD (Washington, D.C.). “truBody helped us create a body sculpting suite – combining both fat reduction and muscle stimulation – in our exclusive S+P MedSpa that offers a complete solution to address the concerns of our patients.”

According to Dr. Somenek, truBody is a customizable, comprehensive treatment using a combination of radiofrequency (RF) for fat reduction with truSculpt and muscle stimulation for toning with truFlex. Individual treatments can be performed in as little as 15 minutes with an average of 24% fat reduction and up to 30% increase in muscle mass.^1,2 “With a complete treatment series, we see noticeable results up to 12 weeks after their last session,” he added.

 Board-certified dermatologist Billie Casse, DO, focuses on whole patient care at her practice, Reno Tahoe Dermatology (Reno, Nev.), and has greatly expanded her patient portfolio thanks to her Body Sculpting Suite. “I had not considered adding body sculpting to my practice as I always considered it to be more in the realm of plastic surgeons,” she explained. “The range of people coming in now are those who want body sculpting but do not want surgery, so adding truBody treatments have been of tremendous value.”

“I think truSculpt technology is one of the safest and most efficient ways to reduce fat, because we can selectively heat subcutaneous tissue and eliminate unwanted fat cells, while protecting the epidermis,” Dr. Casse continued. “truFlex uses multi-directional stimulation with direct bioelectric energy to create muscle confusion. Muscles go through different exercises within a 15-minute period, which tones, sculpts and provides a noticeable improvement in muscle strength and mass. I always recommend the truBody Trim & Tone Protocol with one truSculpt session and four to six truFlex sessions.”

In Dr. Casse’s experience, her patients love it and look forward to coming in for their treatments. “truBody treatments are quick and efficient with no downtime, and patients leave here feeling relaxed and confident that they are getting results.” She added that she is impressed with the range of people who come in for body sculpting consultations. “I always talk to people about both treatments because results can be optimized when used together. My patient interest in truBody has exceeded my expectations.”

Dr. Somenek agrees that truBody has opened the door for new patients and added value to his practice. “The addition of truBody to our practice has certainly increased our menu of services as well as the overall revenue from these treatments,” he explained. “The nonsurgical body contouring market is exponentially growing and truBody offers a comprehensive solution to this need.”

 References:
1. Somenek MT, Ronan SJ, Pittman TA. A Multi-Site, SingleBlinded, Prospective Pilot Clinical Trial for Non-Invasive Fat Reduction of the Abdomen and Flanks Using a Monopolar 2 MHz Radiofrequency Device. Lasers Surg Med. 2021 Mar;53(3):337-343. doi: 10.1002/lsm.23295. Epub 2020 Jul 3. PMID: 32621362.
2. Ronan SJ. A Novel Bio-Electric Current Stimulation Device for Improvement of Muscle Tone [white paper, Cutera Inc.]. 7/2019.

ExoCoBio, a global leader in exosome-based regenerative aesthetics, is pleased to announce that they have completed the acquisition of a majority ownership in BENEV, a global medical aesthetic company based in the U.S.

Founded in 2000, BENEV is a pioneer in the medical aesthetics industry as the manufacturer and distributor of the world's first growth factor-based skincare products. They have expanded their business to market and distribute other innovative medical aesthetics products, including an award-winning RF microneedling system, best-in-class PDO threads, and the Exosome Regenerative Complex developed by ExoCoBio in the U.S. and other countries.

As a leader in these three categories that BENEV calls their "Regenerative Trifecta", the company is one of the fastest growing companies in the U.S. aesthetic medical market, attaining more than 117% CAGR in total revenue over the past 3 fiscal years.

ExoCoBio is an unmatched leader in exosome-based regenerative aesthetics and medicine, and currently holds 54 patents and 15 scientific publications. Their exosome products, ASCE+™ and ERC™ launched in 2019, are the best-in-class next generation exosome products, with over 3.5 million cases sold since the launch.

In March 2023, ASCE+™ and ERC™ product line was awarded "The Best Cosmetics" at The Aesthetic and Anti-aging Medicine World Congress (AMWC), which is the world's pre-eminent global anti-aging congress.

Exosomes are one of the most important categories in this space and are in high demand. 
Exosomes are vesicles composed of various bioactive substances of nano size (30-200 nm) that serve as key signaling molecules between cells in our body. They are secreted for intercellular communication and play a crucial role in inducing immune regulation or activation in recipient cells, thereby influencing the microenvironment surrounding the cells. Exosomes have the potential to target specific cells and enhance the efficacy of active ingredients, making them highly promising for applications in various fields such as cosmetics, diagnostics, and therapeutics.

According to Mr. Byong Cho, CEO/CTO of ExoCoBio, "We are very pleased with this important acquisition which will contribute to the fast growth and business expansion of ExoCoBio. BENEV is a perfect complement to our mission to bridge exosome science to clinical application to further elevate exosome technology as a mega-trend in the market."

Mr. Ethan Min, CEO of BENEV, adds, "We are truly grateful and pleased to announce ExoCoBio's acquisition of BENEV. We have been on a journey together as a strategic and financial partner for the last six years since the U.S. launch of Exosome Regenerative Complex. With this acquisition, we are confident that our expertise, standing in the industry and brand, paired with ExoCoBio's science, technology, funding and pipeline products will generate a strong synergy for our strategic growth in the global medical aesthetic market."   

About ExoCoBio Inc.

ExoCoBio, established in 2017, is the world's leader in exosome-based regenerative aesthetics and medicine. It is one of top 3 exosome biotech companies and commercialized ASCE+™ and ERC™, the world's first and best exosome-based aesthetic products, which led to a new exosome skin booster industry since 2019.

About BENEV Company Inc.

BENEV, established in California in 2000, is an FDA-registered drug manufacturer, specializing mainly in topical solutions for skin and hair, including its exosome products, as well as innovative medical devices such as PDO threads and radiofrequency microneedling device, in the U.S. and around the world. BENEV is an established player in the medical aesthetic market emphasizing health, longevity, and beauty-related products in the U.S., Asia and other marketing around the world. BENEV has a fully integrated business model, which includes manufacturing, research and development, sales, and marketing.

For more information, susan@benev.com

SOURCE BENEV Company Inc.

Sponsored By Hironic;

Treating scars and enlarged pores has traditionally been a challenge for dermatologists, due to side effects or treatments that provide subpar results, until now. One system now offers both diffractive optical element (DOE) and micro lens array (MLA) handpieces using a picosecond laser beam with a pulse duration of 300 ps to provide targeted treatment with little to no side effects. These handpieces provide customizable treatments in multiple sizes and depths to effectively treat scars, enlarged pores, fine lines, wrinkles, skin rejuvenation and even tattoos with safety and efficacy.

“Fractional lasers are well known to decrease scars and pores by stimulating fibroblasts in the dermis and inducing the formation of new collagen. But they have the disadvantage of leaving numerous fine scabs on the face,” explained dermatologist Dong Kee Yu, MD (Korea). “With the DOE and MLA handpieces available on the PICOHI laser system from Hironic (Korea) downtime is shorter than treatment with a fractional laser, and results are further improved through laser induced optical breakdown (LIOB).”

According to Dr. Yu, the DOE handpieces induce LIOB for deep, dermal cavitation. The MLA handpieces are arranged with a small convex lens and generate LIOB at all layers of the skin without damage to the surrounding tissue. “The 300 ps pulse duration of PICOHI is more advantageous to creating LIOB than 450 ps and 750 ps pico lasers,” Dr. Yu reported. “The shorter pulse energy and LIOB induces generation of new collagen for long-term results.” He added that understanding the features of each handpiece and how they work makes it easy to determine how to use them to treat scars and enlarged pores.

Implementation of a stable 300 ps pulse duration ensures only the targeted area is treated, as high peak power and short pulse duration increase LIOB activity for an improved skin rejuvenation effect with a rapid recovery time. “The 1064 nm wavelength is commonly used to treat freckles,” noted Dr. Yu. “In my experience, this laser in combination with the DOE and MLA handpieces, provides a more dramatic improvement for freckles and pigmentation. The PICOHI system is also being used to improve acne scars, pores and skin texture by utilizing the strong LIOB formation.”

In Dr. Yu’s opinion, treating pigmentation with PICOHI works because the phenomenon of LIOB through short pulse duration also improves the overall environment of the dermis. “Improving the environment of the dermis helps remove abnormal melanin pigmentation quickly, while increasing collagen production,” he explained. “My patients notice a brighter and fresher complexion as the diffused reflection is decreased.”

“Treating scars and pores with DOE and MLA handpieces is even more effective when combined with poly DL-type lactic acid (PDLLA),” Dr. Yu continued. “While PDLLA slowly stimulates the fibroblasts over several weeks, PICOHI stimulates the fibroblasts in pulse form according to the treatment cycle.”

Adding the PICOHI system, along with the DOE and MLA handpieces, provides a way for today’s dermatologists and aesthetic physicians to address a variety of indications more efficaciously, which translates to greater benefits for their patients.